|
Ness Technologies'
Raviv Zoeller: Managing others' R&D out of India |
In
a lean period for business news, they would have made headlines.
The past few months, however, as anyone who reads the papers, white
and pink, will aver, have been anything but lean. And so it is,
that three significant developments related to the stockmarket have
almost gone completely unnoticed. The first is the government's
refusal to institute a market stabilisation fund to artificially
prop up the market in case of a bear run. The second is its decision
to allow insurance companies, both state-owned and private sector,
to invest in large and high-quality initial public offerings (IPOs).
And the third is its proposal to amend Section 20 of the Indian
Trusts Act of 1882, to allow trusts to park short-term funds in
securities of their choice instead of those earmarked by the government.
All three point to a common end: the Indian
capital market has come of age. The government would seem to have
decided that it is something that can fend for itself and be opened
up to new players such as insurance companies that typically have
a very long-term perspective of risk and return.
In terms of structural parameters such as operational and systemic
risk management, settlement systems, disclosures norms, and accounting
standards, the Indian securities market is at par with the best
in the world.
Take the case of settlement of stock transactions.
In the UK, weekly settlements are still the norm; the NYSE (New
York Stock Exchange) follows a t+3 system, which means all settlement
must be made within three days of the transaction; but the Indian
stock market has already moved to a t+2 norm (it did so in April
2003). "Even the transparency exhibited in the IPO book-building
process in India is not witnessed in developed markets," contends
Ajay Bagga, CEO, Kotak Mahindra Asset Management Company.
Yet, the Indian stockmarket continues to remain
shallow, vacillating between scams and market misconduct. For instance,
since the second half of the 1990s when the markets became far more
transparent and accessible to millions of middle-class Indians,
they have been ravaged by one scam after another, CRB Mutual Fund
in 1997, the Harshad Mehta scam of 1992 and, again, 1998, UTI in
1998 and, again, 2001, and the Ketan Parekh scam of 2001. And while
the past few years have not witnessed any scams, the Indian stockmarket
is still woefully short of depth and width. In part, this has to
do with the limited free float of shares of many companies. "Since
promoters routinely hold 40 to 50 per cent of the stocks in their
company, there is little free float available making the "impact
cost'' very high for bulk purchases,'' says Bagga. What he means
is that if you want to buy lots of shares of a single company, you
have to pay a very high amount.
And, in part, this has to do with the limited
participation of retail investors and domestic financial institutions.
Today, while foreign institutional investors (FIIs) have invested
around $60 billion (Rs 2,70,000 crore) in the stock market, and
high net worth individuals around $30 billion (Rs 1,35,000 crore),
domestic financial institutions and the retail investor have invested
as little as $15 to $17 billion (Rs 67,500 crore to Rs 76,500 crore).
In the US, retail investors control nearly 50 per cent of the total
stocks in play through pension funds or mutual funds. In numerical
terms, 39 per cent of the American population is an active participant
in the $14 trillion (Rs 6,30,00,000 crore) American stock market;
in India, the corresponding figures are 1.5 per cent and $350 billion
(Rs 15,75,000 crore). Which is where the move to allow pension funds
and insurance companies (both long-term players) to invest in the
stockmarket could help (analysts mention the specifics of higher
liquidity, more stability, and greater depth). After all, it was
President Reagan's decision to allow pension funds to invest in
stocks in 1981 that set off a 15-year bull run in the US.
-Ashish Gupta
ON THE ROAD DEPARTMENT
Bloodline
India's first cord blood stem-cell bank, Lifecell,
opens shop in Chennai. Big Deal? You bet!
|
CRYO-CELL's
Abhaya Kumar: Futureproofing us |
The
future of genetic medicine can be found at Keelakotaiyur in Tamil
Nadu where India's first cord blood stem-cell bank Lifecell will
soon be functional. Stem-cells, for the uninitiated, are super-cells
that are versatile enough to perform a variety of functions and
research is on to condition them to grow into entire organs or parts
of them (think cardiac tissue, lung and liver cells and the like).
The new, researchers hope, can replace the old and the worn within
the human body, increasing longevity and serving as a miracle cure
for degenerative disorders.
This branch of medicine is called regenerative
medicine and it is no longer in the realm of science fiction. Cord-blood,
collected from the umbilical cord, is a rich source of stem-cells
and is already considered a better alternative than anything else
for use in transplants that people suffering from leukemia and other
immune disorders undergo. The cord blood of a newborn can be used
in case it contracts an immunological disease later in life, or
in case any of its siblings does. And, if all goes well, as already
hinted, it can one day help a donor in his or her dotage combat
Parkinson's or multiple sclerosis (yup, stem-cells can treat these
degenerative diseases too).
All this doesn't come cheap. Asia cryo-cell,
promoted by S. Abhaya Kumar, one of the men behind Shasun Chemicals
& Drugs, a Rs 273-crore bulk drugs manufacturer, and which has
a licensing arrangement with the us-based cryo-cell International
Inc., the world's largest cord blood stem cell banking firm, plans
to charge customers a one-time fee of Rs 59,000 or an equivalent
yearly payment, to store the stem-cells for 21 years.
At the end of this period (the newborn is now
old enough to take a decision), the donor can decide whether he
or she wants to continue with the storage. "We are still the
cheapest in Asia," says Abhaya Kumar, the Vice Chairman and
CEO of the company. Asia cryo-cell has invested Rs 12 crore in the
facility and hopes to break even by end-2007, by which time it will
have around 10,000 customers; and this point of inflection factors
in storing the cells for 100 years elsewhere, should the company
go bust, and a contingency storage plan with the Manila Institute
of Life Sciences.
Abhaya Kumar's comment on cost isn't out of
place-it costs anything between $15,000-16,000 (Rs 6.75 lakh-Rs
7.2 lakh) to store cord blood stem-cells for 21 years anywhere else
in the world-but fact is, 75 of the 100 such banks currently present
in the world are public ones that do not charge donors anything
for collection and storage (donors who need stem cells later will,
alas, still have to pay for them and are usually not guaranteed
the return of the very cells they have donated).
Asia cryo-cell itself, discloses Abhaya Kumar,
plans to set up a public bank and charge buyers in line with the
market rates that could be anything upwards of Rs 3 lakh for a match.
The donors though, pay nothing. And cryo-cell plans to use some
samples in the research into diabetes it plans to carry out in association
with the Manila Institute of Life Sciences.
As for the future of medicine, it may not be
as far away as it seems. To date, there have been some 15 transplants
in India involving the use of stem-cells.
-Nitya Varadarajan
Not
Yet, But...
Banks tread thin ice in a desire to leverage
the IPO-financing boom to their benefit.
|
Paper money:
It's boom time for IPO financiers as many companies go public |
The revival of the
initial public offering (IPO) market-thus far, this year, 18 companies
have raised Rs 29,400 crore through IPOs-has meant a boom in IPO-financing
by banks. That's a good sign, and to ensure that nothing goes wrong,
the Reserve Bank of India has put down stringent guidelines for IPO-financing.
For instance, the maximum permissible loan is Rs 10 lakh and that
too, only if the borrower can put down an equal margin (that means
the borrower has to put down Rs 5 lakh). Yet, some banks, it would
seem are violating this, and because this practice is largely being
carried out by 'collecting bankers' the phenomenon hasn't become very
visible.
Here's how this works. Assume that you approach
a 'collecting bank' (bank collecting IPO forms and the money paid)
for a loan of Rs 5 lakh to invest Rs 10 lakh in the same IPO. The
bank takes Rs 5 lakh from you and also gives you a loan of Rs 5
lakh. As the issuing company is authorised to get the money only
after the issue is over, the entire money (Rs 10 lakh) is kept with
the bank itself (in another account). So for the bank, it is just
a book entry (although you, as a borrower, will still have to pay
interest). As most issues are oversubscribed, the banks don't lose
anything. For instance, if the issue is oversubscribed twice over,
and you receive only shares worth Rs 5 lakh (against your application
for Rs 10 lakh worth), the bank will release your money to the issuer
and reverse your loan by another book entry. In that sense, the
banks are making money for nothing.
Herein lies the catch: because this is money
for nothing or "free money", bankers have been tempted
to become more aggressive and finance more of the application amount.
This is against regulations (according to RBI), and it isn't. That's
because, these loans are being masked as normal loans. For instance,
if you are going to apply for Rs 10-lakh worth of shares in an IPO,
the bank can give you a IPO-loan of Rs 5 lakh, and a personal loan
of Rs 4 lakh. That way, your contribution will be just Rs 1 lakh
(or 10 per cent). Here again, the banks will be totally safe if
the issue is oversubscribed by more than 10 times. After all, that
would mean that you just get shares for Rs 1 lakh (the amount you
have actually paid up). Still, it would be foolish to expect that
the current fever of oversubscriptions (downright obscene in some
cases) will continue. And if the market crashes in the middle of
things, the bank may have to take a major hit. Is this within RBI's
control? Indeed, it is; the central bank can simply restrict banks
from lending for IPOs for which they are also 'collecting banks'.
-Narendra Nathan
IDEA
Retail Brotherhood
|
Decades ago, when dairy
farmers in India realised that market middlemen weren't helping
them get the best prices for their products, they launched a cooperative
federation, which today is a giant called Amul. Circa 2005, it's
now the turn of small food retailers to set up a self-help group
of their own-but with the know-how from a Dutch cooperative called
spar. Spearheading the movement in India is Radhakrishna Foodland
(a retail logistics company, and part of the Radhakrishna Group),
which recently obtained a licence from spar to launch a food retailer
cooperative in the country. As in the 34 other countries where spar
operates, the idea in India is to bring together small mom-n-pop
retailers (only food in India's case) and help them with retail
technology, including everything from staffing to training and sourcing
to marketing. Says Raju Shete, Chairman & Managing Director,
Radhakrishna Foodland: "We believe that the entry of the spar
brand into India will usher in a new cooperative model in food retailing,
solely aimed at protecting the interest of the independent retailer
members." The first spar store will open at Juhu in Mumbai
in December this year and will showcase the benefits of retail the
spar way. Given that there are thousands of small and independent
food retailers in the country, Radhakrishna may just cook up a retail
revolution.
-Roshni Jayakar
NEWSMAKER
Phase III Diva
Who is this lady?
Deepanwita Chattopadhyay, CEO, ICICI Knowledge
Park.
Why is she here?
She is CEO of India's best-known biotech and
pharma park (in Hyderabad), which is probably the only professionally
managed research park in India.
And...?
Well, the park is into its third phase now (bookings
complete). The first two phases, that cost Rs 39 crore, saw it build
a total laboratory space of 58,000 sq. ft. that is now occupied
by 14 companies, Indian and multinational. The third phase will
see the construction of an additional 22,000 sq. ft. of lab-space
at a cost of Rs 7 crore.
-E. Kumar Sharma
Brussels,
Madrid, New Delhi, Mumbai
Louis Vuitton's Chairman and CEO insists they
are in the same league.
|
Louis Vuitton's
Yves Carcelle: He can smell the rich a thousand miles away |
It
warms the insides of even a hard-nosed journalist like yours truly
when Mumbai and New Delhi are equated with Brussels, the seat of
the European Union, and Madrid, Spain's most happening city. So,
while Yves Carcelle, Chairman and CEO of the Paris-based fashion
house Louis Vuitton, part of luxury goods major LVMH, is unwilling
to say how much business the brand's first outlet in India, in New
Delhi, does, or how much the second, in Mumbai and it has just opened
for business, hopes to do, he sweetens his refusal by adding that
"Mumbai or Delhi would be in the league of Madrid or Brussels."
He thinks for a moment and adds, "Shanghai is in an altogether
different league of Tier-I cities." One would have guessed
as much, but this isn't about Shanghai (a Tier-I city, according
to Louis Vuitton means independent stores in the city do a business
of around 20 million euros, Rs 119- crore, each); it is about Delhi
and Mumbai; ergo, the happy feeling described in the opening sentence
of this composition.
Then, the realisation sinks in that when Monsieur
Carcelle says Mumbai and Delhi, he is referring to the Mumbai of
the Taj Mahal Hotel, Apollo Bunder and the Delhi of the Oberoi Hotel,
Zakir Hussain Marg where the Louis Vuitton stores are based. "We
usually start in new markets in protected environments such as these,"
says Carcelle. "We don't want to risk having Kentucky Fried
Chicken (KFC) next door." His reference is generic, so this
writer doesn't press the point about KFC having all but exited India
(the last store is in Bangalore, and was still serving chickens
when this magazine went to Press, although an alert on the website
of the Indian arm of PETA, People For Ethical Treatment of Animals,
urges viewers to 'ask KFC to get the cluck out of India') and decides
to eye the merchandise.
The 2,500-sq. ft. store at the Taj stocks a
range of the firm's leather products, shoes, and accessories with
prices ranging from Rs 5,000 for a key chain to Rs 7,00,000 for
a suitcase that obviously goes with this. "When an economy
sees the rate of growth India is seeing, it means several things
are happening," offers Carcelle helpfully, "The most important
is that there is a growing breed of entrepreneurs, corporate executives,
and in India's case, a mass of non resident Indians returning to
participate in the growth here; Bangalore is on the world map; 10
years ago, Indians studying in the us stayed on but today they are
coming back; all this means mindsets are changing and as pioneers
in the fashion business, we see ourselves as market creators and
this is exactly what we are here to do."
In effect, that would mean that the market
for luxury goods in India is no longer restricted to the people
who shop abroad (they will probably still do and you can't catch
them dead in a Louis Vuitton store in India; one in Paris is more
like it) but has moved on to the next lower level.
The tipping point, suggests Carcelle, may have
well been reached. "Some of our closest rivals are eyeing the
market," he says. "The minute we enter a market, they
start assessing it."
-Priya Srinivasan
|